Gynecologic Cancers

Latest News

HPV Self-Collection Test for Cervical Cancer Receives FDA Approval
HPV Self-Collection Test for Cervical Cancer Receives FDA Approval

May 15th 2024

One of the first HPV self-collection solutions has been approved by the FDA, which can identify women at risk of developing cervical cancer.

Image of a checklist that says FDA.
Tisotumab Vedotin-tftv Approved by FDA in Advanced Cervical Cancer

April 29th 2024

Nurse Intervention Approach Feasible in Addressing Cancer Symptom Clusters
Nurse Intervention Approach Feasible in Addressing Cancer Symptom Clusters

April 28th 2024

Inconsistent Symptom Clusters Warrant Routine Assessments in Older Patients With Cancer
Inconsistent Symptom Clusters Warrant Routine Assessments in Older Patients With Cancer

April 25th 2024

FDA Approval of Oncology Drugs in March 2024
FDA Approval of Oncology Drugs in March 2024

April 1st 2024

Video Series
Video Interviews
Podcasts
The Vitals
Oncology Nursing News
Are Hearing Tests Necessary For Adult Cancer Survivors?
Bringing a New Approach to Symptom Management in Ovarian Cancer
Latest CME Events & Activities

Patient, Provider, and Caregiver Connection: Addressing Pediatric and AYA Patient Concerns While Managing Hodgkin Lymphoma

View More

Multidisciplinary Management of TNBC: Immunotherapy, PARP, TROP2, Oh My!

View More

Community Practice Connections™: 14th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies

View More

Community Practice Connections™: The Advent of TROP2-Targeted Treatment Approaches in HR+/HER2- Breast Cancer

View More

8th Annual School of Nursing Oncology™

August 10, 2024

Register Now!

Applying New Evidence in Multiple Myeloma Care from Frontline to R/R Disease

View More

Medical Crossfire®: How Do Clinicians Integrate the Latest Evidence in Treating Ovarian Cancer to Personalize Care?

View More

Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?

View More

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

Medical Crossfire®: Where Are We in the World of ADCs? From HER2 to CEACAM5, TROP2, HER3, CDH6, B7H3, c-MET and Beyond!

View More

Medical Crossfire: How Has Iron Supplementation Altered Treatment Planning for Patients with Cancer-Related Anemia?

View More

The Evolving Tool Box in Advanced HR+/HER2– Breast Cancer: What You Need to Know About Next-Generation SERDs, PI3K/AKT, ADCs, CDK4/6 and Beyond…

View More

Coffee Talk™: Navigating the Impact of HER2/3, TROP2, and PARP from Early Stage to Advanced Breast Cancer Care

View More

More News

© 2024 MJH Life Sciences

All rights reserved.